Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind, Randomized, Multicenter, Active-Comparative, 12-Week Study to Assess the Efficacy and Safety of the Drug in Conjunction With Another Drug in Korean Patients With Primary Hypercholesterolemia

NCT00157911 is registered in ClinicalTrials.gov with Organon and Co as lead sponsor.

NCT NCT00157911
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00157911 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind, Randomized, Multicenter, Active-Comparative, 12-Week Study to Assess the Efficacy and Safety of the Drug in Conjunction With Another Drug in Korean Patients With Primary Hypercholesterolemia
Lead sponsor
Organon and Co
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2002
Completion date
December 31, 2003
Enrollment
136 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hypercholerolemia